Azacitidine: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "* Cytidine analogue used to treat myelodysplastic syndrome and acute myelogenous leukemia * Can cause cytopenias and hepatotoxicity and renal toxicity Category:Medi..." |
(No difference)
|
Revision as of 15:12, 24 February 2022
- Cytidine analogue used to treat myelodysplastic syndrome and acute myelogenous leukemia
- Can cause cytopenias and hepatotoxicity and renal toxicity
References
- ^ Jason A. Trubiano, Michael Dickinson, Karin A. Thursky, Timothy Spelman, John F. Seymour, Monica A. Slavin, Leon J. Worth. Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes. Leukemia & Lymphoma. 2017;58(10):2379-2386. doi:10.1080/10428194.2017.1295141.
